Genotype-derived risk hierarchy in dilated cardiomyopathy
The risk of malignant ventricular arrhythmia (MVA) and end-stage heart failure (ESHF) in dilated cardiomyopathy (DCM) may vary by genotype.1 Comparative analyses remain limited. To compare clinical outcomes and risk predictors across genotypes. Carriers of pathogenic/likely pathogenic variants in DC...